Minimal progress, potential promise in small-cell lung cancer

ONCOLOGY

Volumn 22, Issue 13, 2008, Pages 1495-1496

  Owonikoko, Taofeek ^a   Ramalingam, Suresh ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMRUBICIN; ANTINEOPLASTIC AGENT; BEVACIZUMAB; CISPLATIN; ETOPOSIDE; HISTONE DEACETYLASE INHIBITOR; PLATINUM COMPLEX; TOPOTECAN; VASCULOTROPIN INHIBITOR;

CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFICACY; DRUG RESPONSE; HUMAN; LUNG SMALL CELL CANCER; LYMPH NODE METASTASIS; PLEURA EFFUSION; PROGNOSIS; RADIATION DOSE; REVIEW; SYSTEMIC THERAPY; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CARCINOMA, SMALL CELL; CHEMOTHERAPY, ADJUVANT; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; TUMOR MARKERS, BIOLOGICAL;

EID: 58049088172     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (5)

1. Shepherd FA, Crowley J, Van Houtte P, et al: The International Association for the Study of Lung Cancer lung cancer staging project: Proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer. J Thorac Oncol 2:1067-1077, 2007.
2. Pignon JP, Arriagada R, Ihde DC, et al: A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 327:1618-1624, 1992.
3. Noda K, Nishiwaki Y, Kawahara M, et al: Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med 346:85-91, 2002.
4. Hanna N, Bunn PA Jr, Langer C, et al: Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer. J Clin Oncol 24:2038-2043, 2006.
5. Natale RB, Lana PN, Chansky K, et al: S0124: A randomized phase III trial comparing irinotecan/cisplatin (IP) with etoposide/cisplatin (EP) in patients (pts) with previously untreated extensive stage small cell lung cancer (E-SCLC) (abstract 7512). J Clin Oncol 26(15S):400s, 2008.